George Chigozie Njoku

Mr. George Chigozie Njoku

Cellular physiology and molecular medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
+3
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in Bioactive Materials
Verified
Journal Article
Open access
George Chigozie NjokuGeorge Chigozie Njoku
George Chigozie Njoku
CFCathal Patrick Forkan
Cathal Patrick Forkan
FSFumie Mitani Soltysik
Fumie Mitani Soltysik
PNPeter Lindberg Nejsum
Peter Lindberg Nejsum
FPFlemming Pociot
Flemming Pociot
Reza YaraniReza Yarani
Reza Yarani

Verified
Journal Article
Open access
PDF file
George Chigozie NjokuGeorge Chigozie Njoku
George Chigozie Njoku
GKGeorgette Kanmogne
Georgette Kanmogne
Chronic neuroinflammation and impaired protein clearance are hallmarks of neurodegenerative diseases such as Alzheimer’s disease (AD) and HIV-associated neurocognitive disorders (HAND). Central to these processes are microglia, the brain’s resident immune cells, which normally maintain brain homeostasis by clearing amyloid-beta (Aβ) and other misfolded proteins through phagocytosis and receptor-mediated degradation. However, in both AD and HAND, microglial dysfunction promotes ongoing inflammation, impaired Aβ clearance, and progressive neuronal damage. This review synthesizes evidence from human and animal studies showing how key microglial pattern recognition receptors, including the Triggering receptor expressed on myeloid cells 2 (TREM2), Toll-like receptors (TLRs), and scavenger receptors (SR-AI/II, CD36, SR-BI, CD163), coordinate Aβ sensing, uptake, and inflammatory responses. We describe how HIV infection and viral proteins such as the trans-activator of transcription (Tat) and glycoprotein 120 (gp120) disrupt these pathways by altering receptor expression, lysosomal function, and microglial metabolism, creating a cycle of neurotoxicity and amyloid buildup. We further highlight current scientific gaps in elucidating how HIV affects microglial function and implications for HAND.

23 July 2025 in Communications Biology
Verified
Journal Article
Open access
VSVanshika Sood
Vanshika Sood
HRHannah Ricioli
Hannah Ricioli
George Chigozie NjokuGeorge Chigozie Njoku
George Chigozie Njoku
RPRosita Primavera
Rosita Primavera
SDSusana Dietrich
Susana Dietrich
Reza YaraniReza Yarani
Reza Yarani
Adipose tissue-derived mesenchymal stromal/stem cells (ADMSCs) represent a novel therapeutic intervention for Type 1 Diabetes (T1D). The attractiveness of ADMSCs is characterized by their immunomodulatory activities, regenerative properties, and relative ease of access. ADMSC therapies in animal models and clinical trials have revealed decreased insulin dependence, increased β cell mass, and improved islet graft acceptance. Despite their potential, challenges in quality control, small-scale investigations, functional heterogeneity, and standardization limit the application of these therapies. This review synthesizes the current knowledge and recent outcomes of ADMSC therapies in treating T1D and highlights areas that need further investigation.

1 October 2022 in Journal of the Mexican Chemical Society
Verified
Journal Article
Open access
PDF file
OBOnyedikachi Bliss
Onyedikachi Bliss
EEEmmanuel Ejiofor
Emmanuel Ejiofor
George Chigozie NjokuGeorge Chigozie Njoku
George Chigozie Njoku
MEMaureen Ejiofor
Maureen Ejiofor
KMKanu Michael
Kanu Michael
Oxidative stress arising from free radicals have been documented to be a sponsor of inflammation, driving the search for plant-based compounds with antioxidant and anti-inflammatory activities. The aim of this study was to analyze the chemical composition and evaluate the in vitro antioxidant and anti-inflammatory potentials of essential oil obtained from leaves of Stachytarpheta jamaicensis. Essential oil (EO) was extracted using hydro distillation techniques and its components analyzed using gas chromatograph mass spectrometry (GC-MS) techniques. The antioxidant potentials of the EO were assessed using 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging and ferric ion reducing antioxidant power (FRAP) assays. Anti-inflammatory ability was assessed using inhibition of heat and hypotonicity induced hemolysis of the RBC. GC-MS analysis of essential oil of Stachytarpheta jamaicensis showed the presence of limonene (13.85 %), eucalyptol (10.73 %), linalool (5.36 %), cis verbenol (19.54 %), bornyl acetate (12.65 %) and β-phellandrene (5.59 %) as major EO components, representing a total of 67.72 % of the total volatile fraction. The EO showed strong anti-inflammatory properties and a minimal scavenging potential of DPPH and FRAP activity compared to standard agents used. Result obtained from this study indicates that EO of Stachytarpheta jamaicensis is a promising source of antioxidant and anti-inflammatory agents, which can be exploited in pharmaceuticals. Resumen. Está documentado que el estrés oxidativo originado por radicales libres produce respuestas inflamatorias, lo que ha impulsado la búsqueda de compuestos de origen vegetal con actividades antioxidantes y antiinflamatorias. El objetivo de este estudio fue analizar la composición química y evaluar el potencial antioxidante y antiinflamatorio in vitro del aceite esencial obtenido de las hojas de Stachytarpheta jamaicensis. El aceite esencial (EO, por sus siglas en inglés) se extrajo mediante técnicas de hidrodestilación y sus componentes se analizaron mediante técnicas de cromatografía de gases y espectrometría de masas (GC-MS). El potencial antioxidante del aceite esencial se evaluó utilizando ensayos con 2,2-difenil-1-picrilhidrazilo (DPPH) y evaluando el poder reductor de iones férricos (FRAP). La capacidad antiinflamatoria se evaluó mediante la inhibición de la hemólisis de los glóbulos rojos inducida por calor e hipotonia. El análisis GC-MS del aceite esencial de Stachytarpheta jamaicensis mostró la presencia de limoneno (13,85 %), eucaliptol (10,73 %), linalol (5,36 %), cis-verbenol (19,54 %), acetato de bornilo (12,65 %) y β-felandreno (5,59 %) como componentes mayoritarios del extracto, representando un total de 67,72 % de la fracción volátil total. El extracto mostró propiedades antiinflamatorias y un potencial depurador mínimo de la actividad de DPPH y FRAP en comparación con los agentes utilizados como estándares. El resultado obtenido de este estudio indica que el aceite esencial de Stachytarpheta jamaicensis es una fuente prometedora de compuestos antioxidantes y antiinflamatorios, que pueden explotarse en productos farmacéuticos.

15 January 2022 in Asian Journal of Research in Biochemistry
Verified
Journal Article
Closed access
PDF file
PAPrince O. Alaebo
Prince O. Alaebo
COChimaraoke Onyeabo
Chimaraoke Onyeabo
COChinwe E. Oriaku
Chinwe E. Oriaku
George Chigozie NjokuGeorge Chigozie Njoku
George Chigozie Njoku
DIDavid U. Iloanusi
David U. Iloanusi
PEPeter O. Ekwunoh
Peter O. Ekwunoh
Purpose: The study investigated honey's hepatoprotective effect and lipid profile on alloxan-induced diabetic rats. Methods: Thirty-six (36) male Wistar rats were assigned into six (6) groups with six (6) animals each, group 1 (Normal control), group 2 (Negative control), group 3 (Glibenclamide), group 4 (treated with 0.2mls of honey) group 5, (treated with 0.5mls of honey and group 6 (treated with 0.8mls of honey). The rats were fed with standard feed and drinking water ad libitum. The diabetic control, diabetic glibenclamide and the treated groups (0.2 mL/kg, 0.5 mL/kg and 0.8 mL/kg) were induced with diabetes by intraperitoneal injection of 120 mg/kg bodyweight alloxan monohydrate, and confirmation was done using a glucometer. Treatment lasted for three weeks (21 days), after which rats were sacrificed by cervical dislocation under light ether anaesthesia. Blood was collected for biochemical evaluation using standard techniques (Randox kits). Blood glucose levels were monitored on days 0, 7, 14, and 21. Results: Administration of honey to the diabetic rats significantly reduced (p < 0.05) glucose level (119.50 mg/dl), total cholesterol (TC), triglyceride (49.5 mg/dl) and low-density lipoprotein cholesterol (LDL-C), while significantly increasing (p < 0.05) high-density lipoprotein cholesterol (HDL-C) when compared to the diabetic untreated rats. Liver enzyme parameters: alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and total bilirubin (T.Bil.) were found to be within the normal range. Conclusions: Overall, the findings suggest that honey could ameliorate metabolic disorders caused by diabetes.

30 July 2022 in GSC Biological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
KEKingsley C Eze
Kingsley C Eze
CUCalister E Ugwu
Calister E Ugwu
IEIheanacho O Enyum
Iheanacho O Enyum
FOFimber S Odo
Fimber S Odo
George Chigozie NjokuGeorge Chigozie Njoku
George Chigozie Njoku
Background: Hunteria umbellata (HU) is a tropical rainforest shrub in the Apocynaceae family, with various medicinal properties. Nanostructured systems improve pharmacokinetic and pharmacodynamic properties of bioactive compounds. The current study evaluates the antidiabetic and wound healing efficacy of Hunteria umbellata-chitosan nanoparticles (HUCNPs). Methods: Aqueous seed extract was prepared from mature HU pods. Chitosan nanoparticles of H. umbellata were created by ionic gelation of chitosan with tripolyphosphate anions (TPP) and characterized using Dynamic light scattering (DLS) and Fourier Transform Infrared Spectroscopy (FT-IR). The streptozotocin-induced diabetic rat model and wound excision model were used to investigate the antidiabetic activity and wound healing efficacy of HUCNPs. Serum biochemical marker enzymes and antioxidants from kidney and liver tissues were quantified. Result: FT-IR confirmed the successful cross linkage of bioactive compounds to the chitosan nanoparticles. HUCNPs had particle size of 408.6 ± 1.5 nm, zeta potential of 32.4 ± 1.6, and polydispersity index of 0.47. Rats treated with HUCNPs had a significantly reduced mean fasting blood glucose level. Serum levels of Glutamic oxaloacetic transaminase (SGOT), glutamic pyruvic transaminase (SGPT), and alkaline phosphatase were closer to normal than diabetic control. Catalase (CAT), reduced glutathione (GSH), and superoxide dismutase (SOD) levels were higher in HUCNPs-treated liver and kidney tissues, while lipid peroxidase (LPO) levels were lower. The topical application of the HUCNPs ointment significantly accelerated wound healing (81.6 %) and prevented the microbial invasion of the wound surface. Conclusion: This study suggests HUCNPs as an excellent strategy for targeted drug delivery for diabetes management and accelerated wound healing.